Variant report
Variant | nsv520185 |
---|---|
Chromosome Location | chr9:7229073-7233161 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373201725 | chr9:7229210-7229211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11792446 | chr9:7229211-7229212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11793854 | chr9:7229214-7229215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145007632 | chr9:7229215-7229216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542196496 | chr9:7229216-7229217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528532188 | chr9:7229230-7229231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548954572 | chr9:7229239-7229240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546674153 | chr9:7229249-7229250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531833276 | chr9:7229302-7229303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564968853 | chr9:7229311-7229312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532400825 | chr9:7229339-7229340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562413550 | chr9:7229383-7229384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10117675 | chr9:7229427-7229428 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs569811606 | chr9:7229438-7229439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537270671 | chr9:7229443-7229444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549162537 | chr9:7229470-7229471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146948670 | chr9:7229471-7229472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567450939 | chr9:7229484-7229485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534733320 | chr9:7229487-7229488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553099921 | chr9:7229512-7229513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs117558154 | chr9:7229527-7229528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564307553 | chr9:7229568-7229569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538215232 | chr9:7229569-7229570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533288590 | chr9:7229593-7229594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549843722 | chr9:7229597-7229598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138257012 | chr9:7229604-7229605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575820551 | chr9:7229631-7229632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10120936 | chr9:7229645-7229646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554776906 | chr9:7229653-7229654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573082840 | chr9:7229655-7229656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540376554 | chr9:7229674-7229675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149133569 | chr9:7229768-7229769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550801391 | chr9:7229803-7229804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143302923 | chr9:7229815-7229816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544250734 | chr9:7229816-7229817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563580255 | chr9:7229826-7229827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191209982 | chr9:7229880-7229881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79238020 | chr9:7229888-7229889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530746331 | chr9:7229943-7229944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549274740 | chr9:7229949-7229950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567513230 | chr9:7229972-7229973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148317211 | chr9:7229998-7229999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76491894 | chr9:7230004-7230005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34234144 | chr9:7230067-7230068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571206899 | chr9:7230071-7230072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7849079 | chr9:7230101-7230102 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs181601153 | chr9:7230108-7230109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568820192 | chr9:7230117-7230118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs117046540 | chr9:7230133-7230134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554842342 | chr9:7230135-7230136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:7229200-7238000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr9:7229400-7229600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr9:7231000-7231200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr9:7231200-7233600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr9:7231200-7239400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr9:7231200-7239800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr9:7231800-7235200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |